{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:40:00Z","timestamp":1790862000484,"version":"4.1.0"},"reference-count":50,"publisher":"Archives of Endocrinology and Metabolism","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Endocrinol. Metab."],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1590\/2359-3997000000274","type":"journal-article","created":{"date-parts":[[2017,7,9]],"date-time":"2017-07-09T15:49:14Z","timestamp":1499615354000},"page":"305-312","source":"Crossref","is-referenced-by-count":67,"title":["Diagnosis and management of primary aldosteronism"],"prefix":"10.20945","volume":"61","author":[{"given":"Leticia A. P.","family":"Vilela","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madson Q.","family":"Almeida","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil; USP, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the global burden of disease","volume":"369","author":"Murray CJ","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"ref2","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan BM","year":"2010","journal-title":"JAMA"},{"issue":"9161","key":"ref3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(98)06102-9","article-title":"Mineralocorticoid hypertension","volume":"353","author":"Stewart PM","year":"1999","journal-title":"Lancet"},{"issue":"5262","key":"ref4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.272.5262.676","article-title":"Molecular genetics of human blood pressure variation","volume":"272","author":"Lifton RP","year":"1996","journal-title":"Science"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan RS","year":"2004","journal-title":"N Engl J Med"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder G","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1253\/circj.71.915","article-title":"Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure","volume":"71","author":"Tsutamoto T","year":"2007","journal-title":"Circ J"},{"issue":"24","key":"ref8","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui F","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000087842","article-title":"Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives","volume":"28","author":"Tylicki L","year":"2005","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies--a review of the current literature","volume":"44","author":"Hannemann A","year":"2012","journal-title":"Horm Metab Res"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ndt\/gfh112","article-title":"Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension","volume":"19","author":"Plouin PF","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"9628","key":"ref12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma S","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun DA","year":"2002","journal-title":"Hypertension"},{"issue":"25","key":"ref14","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun DA","year":"2008","journal-title":"Circulation"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez P","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser M","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard S","year":"2013","journal-title":"Hypertension"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero P","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo F","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis","volume":"183","author":"Chen W","year":"2014","journal-title":"Ir J Med Sci"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder JW","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi GP","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder JW","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi GP","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed AH","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/jc.2011-2504","article-title":"Confirmatory testing in primary aldosteronism","volume":"97","author":"Nanba K","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","article-title":"Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma","volume":"25","author":"Rossi GP","year":"2007","journal-title":"J Hypertens"},{"issue":"4","key":"ref28","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos RT","year":"1995","journal-title":"Endocr Rev"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers T","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","article-title":"Hyperaldosteronism: sampling the adrenal veins","volume":"198","author":"Doppman JL","year":"1996","journal-title":"Radiology"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1210\/jc.2016-1011","article-title":"Impact of New Quick Gold Nanoparticle-Based Cortisol Assay During Adrenal Vein Sampling for Primary Aldosteronism","volume":"101","author":"Yoneda T","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi GP","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and Post-ACTH Aldosterone and Its Ratios Are Useful During Adrenal Vein Sampling in Primary Aldosteronism","volume":"101","author":"El Ghorayeb N","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"ref34","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland DJ","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"6357","key":"ref35","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton RP","year":"1992","journal-title":"Nature"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"Mulatero P","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood","volume":"138","author":"Dluhy RG","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","article-title":"Glucocorticoid-remediable aldosteronism","volume":"84","author":"Dluhy RG","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0031-1299730","article-title":"The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience","volume":"44","author":"Pallauf A","year":"2012","journal-title":"Horm Metab Res"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty AR","year":"2000","journal-title":"J Med Genet"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl UI","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller DS","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi GP","year":"2008","journal-title":"Hypertension"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena C","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen O","year":"1996","journal-title":"Arch Surg"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka AM","year":"2001","journal-title":"Ann Intern Med"},{"issue":"18","key":"ref47","first-page":"647","article-title":"Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn\u2019s syndrome (author\u2019s transl)","volume":"105","author":"Wambach G","year":"1980","journal-title":"Dtsch Med Wochenschr"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre X","year":"1987","journal-title":"Am J Cardiol"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess ED","year":"2003","journal-title":"Clin Ther"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy HK","year":"2011","journal-title":"J Hypertens"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aem\/v61n3\/0004-2730-aem-61-3-0305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T01:57:53Z","timestamp":1569722273000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972017000300305&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2359-39972017000300305"],"URL":"https:\/\/doi.org\/10.1590\/2359-3997000000274","relation":{},"ISSN":["2359-3997"],"issn-type":[{"value":"2359-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}